NCT06597149View on ClinicalTrials.gov

Effect of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Plasma Insulin Levels

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2027

Conditions
Healthy
Interventions
DEVICE

Transcutaneous Auricular Vagus Nerve Stimulation

Healthy adult participants will be assigned to either the stimulation group or the sham group. The stimulation group will receive mild stimulation from the TeNS device and the sham group will receive no stimulation but will believe that they are receiving stimulus.

Trial Locations (1)

46202

RECRUITING

Indiana University Hospital, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER